Literature DB >> 508681

Systemic absorption of topical and subconjunctival gentamicin.

G E Trope, J R Lawrence, V M Hind, A Everden.   

Abstract

Ten patients received ocular gentamicin therapy topically or subconjunctivally. Systemic absorption was not detected after topical use but was detected after subconjuctival administration. The relative safety of ocular gentamicin therapy is discussed and the literature is reviewed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508681      PMCID: PMC1043595          DOI: 10.1136/bjo.63.10.692

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Penetration and systemic absorption of gentamicin after subconjunctival injection.

Authors:  M B Mathalone; A Harden
Journal:  Br J Ophthalmol       Date:  1972-08       Impact factor: 4.638

2.  Penetration of gentamicin into the aqueous humor of human eyes.

Authors:  F P Furgiuele
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

3.  Kinetic model for gentamicin dosing with the use of individual patient parameters.

Authors:  R J Sawchuk; D E Zaske; R J Cipolle; W A Wargin; R G Strate
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

4.  Simplified assay for gentamicin in the presence of other antibiotics.

Authors:  D V Alcid; S J Seligman
Journal:  Antimicrob Agents Chemother       Date:  1973-05       Impact factor: 5.191

  4 in total
  2 in total

Review 1.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

2.  Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.

Authors:  William R Ravis; Alejandro Llanos-Cuentas; Nestor Sosa; Mara Kreishman-Deitrick; Karen M Kopydlowski; Carl Nielsen; Kirsten S Smith; Philip L Smith; Janet H Ransom; Yuh-Jing Lin; Max Grogl
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.